SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tunica Albuginea who wrote (13108)8/11/1998 11:48:00 PM
From: VLAD  Read Replies (1) of 23519
 
TA,

Two more points:

As I mentioned earlier, I was told by Vivus that a well respected German cardiologist is soon to present a paper demonstrating the serious cardiovascular side effect of PDE inhibitors on the cardiac patient. IMO, this presentation will be damning to Viagra.

Also, don't be surprised if Pfizer doesn't attempt a hostile take over of Vivus if this type of price action continues. With both Viagra and MUSE under their control, they would have a virtual monopoly on the ED market and their reps could demo both products in the same breath. Also. Pfizer would then have both J&J and Astra eating out of their hands to supply them with MUSE. Interesting possibility.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News